Sort
35,931 grants matching “parkinsons”
Aging and Parkinson's Disease: Models of Therapeutics and Neurologic Comorbidity
$1,142,463Timothy J. Collier · Michigan State University · P50 · FY2012 · NS
Molecular &Behavioral Effects of Low Level Mn Exposure
$1,142,463Johns Hopkins University · R01 · FY2004 · ES
A Clinical Trial of AAV2-BDNF Gene Therapy in Alzheimer's Disease
$1,141,927Mark H Tuszynski · University Of California, San Diego · R01 · FY2022 · AG
Dissecting Oligogenic Biomarkers in Ashkenazi Jews with Parkinson Disease
$1,141,563Rachel Saunders-Pullman · Icahn School Of Medicine At Mount Sinai · U01 · FY2019 · NS
Role of molecular chaperones in protein folding diseases
$1,140,600Lois Greene · National Heart, Lung, And Blood Institute · ZIA · FY2019 · HL
Mechanisms of axon guidance during development
$1,140,478Edward Giniger · National Institute Of Neurological Disorders And Stroke · ZIA · FY2013 · NS
Molecular Genetics Of Scrapie Pathogenesis
$1,139,579Suzette Alise Priola · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
Deciphering innate immune signaling mechanisms in glial cells linking lifetime environmental exposures to neuroinflammation, protein aggregation and neurodegeneration in Parkinsons disease
$1,139,354Ronald B Tjalkens · Colorado State University · R35 · FY2023 · ES
LONGTERM CHANGES IN THE MAMMALIAN BRAIN
$1,139,036University Of California San Francisco · P50 · FY2000 · MH
Molecular Genetics Of Early Eye Development
$1,139,032Stanislav I Tomarev · National Eye Institute · ZIA · FY2024 · EY
Detection of Prions
$1,137,875Byron Caughey · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI
Parkinson's Disease Data Organizing Center
$1,137,270Roger M Kurlan · University Of Rochester · U01 · FY2010 · NS
Phase III Trial of Minocycline in ALS:I-Clinical Center
$1,136,760Columbia University Health Sciences · R01 · FY2004 · NS
Human Embryonic Stem Cells: Characterization and Dopaminergic Differentiation
$1,136,747William Freed · National Institute On Drug Abuse · ZIA · FY2012 · DA
Innovating next generation technologies to define mechanisms of neurodegenerative disease and devise therapeutic strategies
$1,136,484Aaron D. Gitler · Stanford University · R35 · FY2025 · NS
Molecular Genetics Of Scrapie Pathogenesis
$1,135,879Suzette Alise Priola · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI
UCLA CENTER FOR THE STUDY OF PARKINSON'S DISEASE
$1,135,852University Of California Los Angeles · P50 · FY2003 · NS
A consortium effort to translate therapies for neurological diseases via an ex vivo organotypic platform
$1,135,383Shawn Hingtgen · Univ Of North Carolina Chapel Hill · U01 · FY2023 · TR
Assessment of Candidate Loci in Neurological diseases
$1,135,220Andrew Singleton · National Institute On Aging · ZIA · FY2021 · AG
DBS-Expert Pro: Automated Deep Brain Stimulation Programming Using Functional Mapping
$1,134,607Dustin Allen Heldman · Great Lakes Neurotechnologies · R44 · FY2025 · NS
Subthalamic and corticosubthalamic coding of speech production
$1,134,330Robert Mark Richardson · University Of Pittsburgh At Pittsburgh · U01 · FY2018 · NS
MITOCHONDRIAL ETIOLOGIES OF PARKINSON'S DISEASE
$1,134,015University Of Virginia Charlottesville · P50 · FY2002 · NS
FAMILIAL PARKINSON'S DISEASE: CLUES TO PATHOGENESIS
$1,133,503Brigham And Women'S Hospital · P50 · FY2004 · NS
Peripheral Tissue Biomarker for Premortem Diagnosis of Lewy Body Dementia
$1,133,032Shu G Chen · Case Western Reserve University · R01 · FY2020 · NS
Innovating Yeast and Human Genetics Approaches to Define Mechanisms of Neurodegenerative Disease
$1,132,610Aaron D. Gitler · Stanford University · R35 · FY2020 · NS